Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system

Neurobiology of Disease

Volumn 3, Issue 4, 1997, Pages 313-323

  Brooks, Brian P ^a   Paulson, Henry L ^a   Merry, Diane E ^a   Salazar Grueso, Edgar F ^b   Brinkmann, Albert O ^c   Wilson, Elizabeth M ^d   Fischbeck, Kenneth H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ANIMAL CELL; ARTICLE; GENE MUTATION; LIGAND BINDING; MOTONEURON; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; REPORTER GENE; SPINAL MUSCULAR ATROPHY;

EID: 0030890733     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0126     Document Type: Article

References (39)

1. Ausubel F. M., Brent R., Kingston R., Moore D. D., Smith J. A., Seidman J. G., Struhl K. Current Protocols in Molecular Biology. 1987;Greene/Wiley Interscience, New York.
2. Banfi S., Servadio A., Chung M. Y., Kwiatkowski T. J., McCall A. E. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nature Genet. 7:1994;513-520.
3. Bowling A. C., Beal M. F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56:1995;1151-1171.
4. Brooks B. P., Fischbeck K. H. Spinal and bulbar muscular atrophy: A trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci. 18:1995;459-461.
5. Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82:1995;937-948.
6. Chamberlain N. L., Driver E. D., Miesfeld R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:1994;3181-3186.
7. Choong C. S., Kemppainen J. A., Zhou Z. X., Wilson E. M. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol. 10:1996;1527-1535.
8. Danek A., Witt T. N., Mann K., Schweikert H. U., Romalo G., LaSpada A. R., Fischbeck K. H. Decrease in androgen binding and effect of androgen treatment in a case of X-linked bulbospinal neuronopathy. Clin. Invest. 72:1994;892-897.
9. Fukuchi K., Hearn M. G., Deeb S. S., Smith A. C., Dang N. Activity assays of nine heterogeneous promoters in neural and other cultured cells. In Vitro Cell. Dev. Biol. 30A:1994;300-305.
10. Hansen M. B., Nielson S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Meth. 119:1989;203-210.
11. Cell. 72:1993;971-983.
12. Ikeda H., Yamaguchi M., Sugai S., Aze Y., Narumiya S., Kakizuka A. Expanded polyglutamine in the Machado-Joseph disease protein induces cell deathin vitroin vivo. Nature Genet. 13:1996;196-202.
13. Imagawa M., Ishikawa Y., Shimano H., Osada S., Nishihara T. CTG triplet repeat in mouse growth inhibitory factor/metallothionein III gene promoter represses the transcriptional activity of the heterologous promoters. J. Biol. Chem. 270:1995;20898-20900.
14. Jenster G., Trapman J., Brinkmann A. O. Nuclear import of the human androgen receptor. Biochem. J. 293:1993;761-768.
15. Jenster G., de Ruiter P. E., van der Korput H. A., Kuiper G. G., Trapman J., Brinkmann A. O. Changes in the abundance of androgen receptor isotypes: Effects of ligand treatment, glutamine-stretch variations, and mutation of putative phosphorylation sites. Biochemistry. 33:1994;14064-14072.
16. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet. 8:1994;221-227.
17. Kazemi-Esfarjani P., Beitel L. K., Trifiro M., Kaufman M., Rennie P., Sheppard P., Matusik R., Pinksy L. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Mol. Endocrinol. 7:1993;37-46.
18. n. Hum. Mol. Genet. 4:1995;523-527.
19. Kemppainen J. A., Lane M. V., Sar M., Wilson E. M. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J. Biol. Chem. 267:1992;968-974.
20. Koide R., Ikeuchi T., Onodera O., Tanaka H., Igarashi S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet. 6:1994;9-13.
21. LaSpada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 352:1991;77-79.
22. Matsuura T., Demura T., Aimoto Y., Mizono T., Moriwaka F., Tashiro K. Androgen receptor abnormality in X-linked spinal and bulbar muscular atrophy. Neurology. 42:1992;1724-1726.
23. Mhatre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet. 5:1993;184-188.
24. Nagafuchi S., Yanagisawa H., Ohsaki E., Shirayama T., Tadokoro K. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nature Genet. 8:1994a;177-182.
25. Nagafuchi S., Yanagisawa H., Sato K., Shirayama T., Ohsaki E. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6:1994b;14-18.
26. Nakamura M., Mita S., Murakami T., Uchino M., Watanabe S. Exonic trinucleotide repeats and expression of androgen receptor gene in spinal cord from X-linked spinal and bulbar muscular atrophy. J. Neurol. Sci. 122:1994;74-79.
27. Orr H. T., Chung M.-Y., Banfi S., Kwiatkowski T. J., Servadio A. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4:1993;221-226.
28. Perutz M. F., Johnson T., Suzuki M., Finch J. T. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 91:1994;5355-5358.
29. Pinsky L., Trifiro M., Kaufman M., Beitel L. K., Mhatre A. Androgen resistance due to mutation of the androgen receptor. Clin. Invest. Med. 15:1992;456-472.
30. Salazar-Grueso E. F., Kim S., Kim H. Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport. 2:1991;505-508.
31. Sar M., Stumpf W. E. Androgen concentration in motor neurons of cranial nerves and spinal cord. Science. 197:1977;77-79.
32. Simental J. A., Sar M., Lane M. V., French F. S., Wilson E. M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266:1991;510-518.
33. Stott K., Blackburn J. M., Butler P. J., Perutz M. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA. 92:1995;6509-6513.
34. Thor H., Smith M. T., Hartzell P., Bellomo G., Jewell S. A., Orrenius A. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. J. Biol. Chem. 257:1982;12419-12425.
35. Trupp M., Arenas E., Fainzilber M., Nilsson A. S., Sieber B. A. Functional receptor for GDNF encoded by the c-ret. Nature. 381:1996;785-788.
36. Tsai M. J., O'Malley B. W. Molecular mechanisms of actionof steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
37. Warner C. L., Griffin J. E., Wilson J. D., Jacobs L. D., Murray K. R. X-linked spinomuscular atrophy: A kindred with associated abnormal androgen receptor binding. Neurology. 42:1992;2181-2184.
38. Zegers N. D., Claasen E., Neelen C., Mulder E., van Laar J. H. Epitope prediction and confirmation for the human androgen receptor: Generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochim. Biophys. Acta. 1073:1991;23-32.
39. Zhou Z. X., Wong C. I., Sar M., Wilson E. M. The androgen receptor: An overview. Rec. Prog. Horm. Res. 49:1994;249-274.